341 related articles for article (PubMed ID: 25672594)
21. Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein using PLGA nanoparticles to induce chondrogenesis of human mesenchymal stem cells.
Jeon SY; Park JS; Yang HN; Lim HJ; Yi SW; Park H; Park KH
Biomaterials; 2014 Sep; 35(28):8236-48. PubMed ID: 24965885
[TBL] [Abstract][Full Text] [Related]
22. Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo.
Zhu Q; Pan X; Sun Y; Wang Z; Liu F; Li A; Zhao Z; Wang Y; Li K; Mi L
PLoS One; 2017; 12(10):e0185507. PubMed ID: 28985230
[TBL] [Abstract][Full Text] [Related]
23. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
24. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
Li C; Chen D; Luo M; Ge M; Zhu J
Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
[TBL] [Abstract][Full Text] [Related]
26. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
Jeon SY; Park JS; Yang HN; Woo DG; Park KH
Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
[TBL] [Abstract][Full Text] [Related]
27. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model.
Scheinman RI; Trivedi R; Vermillion S; Kompella UB
Nanomedicine (Lond); 2011 Dec; 6(10):1669-82. PubMed ID: 22087799
[TBL] [Abstract][Full Text] [Related]
28. Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells.
Frasco MF; Almeida GM; Santos-Silva F; Pereira Mdo C; Coelho MA
J Biomed Mater Res A; 2015 Apr; 103(4):1476-84. PubMed ID: 25046528
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.
Miwa T; Kokuryo T; Yokoyama Y; Yamaguchi J; Nagino M
Cancer Med; 2015 Jul; 4(7):1091-100. PubMed ID: 25914189
[TBL] [Abstract][Full Text] [Related]
30. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
31. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
32. siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.
Stigliano C; Aryal S; de Tullio MD; Nicchia GP; Pascazio G; Svelto M; Decuzzi P
Mol Pharm; 2013 Aug; 10(8):3186-94. PubMed ID: 23789777
[TBL] [Abstract][Full Text] [Related]
33. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
34. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
[TBL] [Abstract][Full Text] [Related]
35. The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells.
Sato F; Kawamura H; Wu Y; Sato H; Jin D; Bhawal UK; Kawamoto T; Fujimoto K; Noshiro M; Seino H; Morohashi S; Kato Y; Kijima H
Int J Mol Med; 2012 Sep; 30(3):495-501. PubMed ID: 22735690
[TBL] [Abstract][Full Text] [Related]
36. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
37. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
38. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
39. Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer.
Daman Z; Faghihi H; Montazeri H
Drug Dev Ind Pharm; 2018 Sep; 44(9):1434-1442. PubMed ID: 29619850
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression.
Büchler P; Reber HA; Büchler MW; Friess H; Lavey RS; Hines OJ
Cancer; 2004 Jan; 100(1):201-10. PubMed ID: 14692041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
